Vertex Pharmaceuticals, Inc’s recently made public that its Officer ALTSHULER DAVID acquired Company’s shares for reported $1.58 million on Mar 03 ’25. In the deal valued at $490.00 per share,3,231 shares were bought.
Then, Tatsis Ourania sold 530 shares, generating $251,930 in total proceeds. Upon selling the shares at $475.34, the EVP, Chief Reg. & Quality Off. now owns 58,539 shares.
Before that, Atkinson Edward Morrow III sold 2,650 shares. Vertex Pharmaceuticals, Inc shares valued at $1,259,651 were divested by the EVP, Chief Technical Ops. Off. at a price of $475.34 per share. As a result of the transaction, Atkinson Edward Morrow III now holds 19,352 shares, worth roughly $9.35 million.
Canaccord Genuity upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Hold from a a Sell in a research note published on February 12, 2025; the price target was increased to $424 from $408. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who increased its forecast for the stock in mid February from “a Sell” to “a Hold”. Wells Fargo also remained covering VRTX and has decreased its forecast on January 30, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. H.C. Wainwright maintained its rating on December 20, 2024. It rated VRTX as “a Buy”.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 0.73% to $483.31. Over the last five days, the stock has gained 0.34%. Vertex Pharmaceuticals, Inc shares have risen nearly 20.02% since the year began. Nevertheless, the stocks have risen 13.20% over the past one year. While a 52-week high of $519.88 was reached on 02/05/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $442.18, while 200 days put it at $465.98.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 477.14, which if violated will result in even more drops to 470.98. On the upside, there is a resistance level at 490.06. A further resistance level may holdings at 496.82. The Relative Strength Index (RSI) on the 14-day chart is 62.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.26, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 16.44%. Stochastics %K at 77.89% indicates the stock is a holding.
